Tiludronate (Tildren® and Skelid®) Use in Horses
  by Robert N. Oglesby DVM

Tiludronate, classified a bisphosphonates type drug, is indicated for use in humans that have conditions of excessive bone loss, like Paget's disease. It is available in several commercial products including Tildren and Skelid. In 2003 a large well designed study found that in carefully selected cases of lame horses with evidence of navicular bone disease found the use of tiludronate beneficial. This was followed by a positive report in its use in horses with throacolumbar osteoarthritis and it's ability to reduce bone loss during restricted movement like might be experienced in a cast leg. Since then there have been reports of several different bone and joint disease being treated with this drug. In this article we explore what is known about the use of this drug in horses and dosage regimens.

You have just read the introduction to one of our nearly 800 articles on horse care, diseases, and training. It includes a description of the contents of the unabridged version. As a guest you can access this article two different ways: either purchase the article or become a member and take advantage of all the benefits Horseadvice.com has to offer. Check out our Membership Drive Discount below but hurry. This is for a limited time!